OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 162 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $349,000 | +2808.3% | 812,558 | +3741.5% | 0.00% | – |
| Q1 2016 | $12,000 | -40.0% | 21,152 | +83.8% | 0.00% | – |
| Q4 2015 | $20,000 | -94.4% | 11,511 | -93.2% | 0.00% | – |
| Q3 2015 | $356,000 | -29.4% | 168,577 | +65.5% | 0.00% | – |
| Q2 2015 | $504,000 | +51.8% | 101,866 | +140.1% | 0.00% | – |
| Q1 2015 | $332,000 | -73.1% | 42,435 | -79.2% | 0.00% | -100.0% |
| Q4 2014 | $1,235,000 | +318.6% | 203,680 | +194.6% | 0.00% | – |
| Q3 2014 | $295,000 | -9.8% | 69,149 | +30.6% | 0.00% | – |
| Q2 2014 | $327,000 | +7.6% | 52,936 | +13.2% | 0.00% | – |
| Q1 2014 | $304,000 | -22.3% | 46,744 | -32.6% | 0.00% | -100.0% |
| Q4 2013 | $391,000 | -95.3% | 69,376 | -94.8% | 0.00% | -92.3% |
| Q3 2013 | $8,260,000 | +39.0% | 1,345,357 | +32.4% | 0.01% | +30.0% |
| Q2 2013 | $5,942,000 | – | 1,015,804 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 5,427,559 | $2,334,000 | 1.60% |
| Scale Management, LLC | 1,312,575 | $564,000 | 1.34% |
| Foresite Capital Management III, LLC | 2,542,575 | $1,093,000 | 0.75% |
| BVF INC/IL | 5,252,100 | $2,258,000 | 0.48% |
| TIVERTON ASSET MANAGEMENT LLC | 45,313 | $4,261,000 | 0.18% |
| Baupost Group | 22,268,399 | $9,575,000 | 0.13% |
| Rhenman & Partners Asset Management AB | 1,200,000 | $516,000 | 0.09% |
| NEA Management Company, LLC | 370,900 | $1,595,000 | 0.08% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $2,649,000 | 0.06% |
| Palo Alto Investors LP | 1,673,024 | $719,000 | 0.05% |